Etat membre d'origine / Choix de l’autorité compétente pour le contrôle de l’information réglementée

 

Press release – For immediate release March 14, 2025 – 5:45 pm CET

 

Median Technologies meets the eligibility conditions  for the PEA-PME scheme

 

 

Sophia Antipolis, France – Median Technologies (FR0011049824, ALMDT) confirms its eligibility for the PEA-PME scheme in accordance with the provisions of Articles L. 221-32-2 and D. 221-113-5 and following of the Monetary and Financial Code specifying the conditions for assessing the eligibility criteria, i.e.:

•       Less than 5,000 employees,

•       An annual turnover of less than 1.5 billion euros or a balance sheet total of less than 2 billion euros.

Median Technologies shares therefore continue to be included in PEA-PME accounts, which for the record benefit from the same tax advantages as the traditional stock savings plan (PEA).

 

 

 

About Median Technologies: Pioneering innovative imaging solutions and Software as a Medical Device, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S.

and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.

Contacts

 

MEDIAN TECHNOLOGIES Emmanuelle Leygues VP, Corporate Marketing & Financial Communications +33 6 10 93 58 88 emmanuelle.leygues@mediantechnologies.com	U.S. media & investors  Chris Maggos COHESION BUREAU +41 79 367 6254 chris.maggos@cohesionbureau.com
Investors  Ghislaine Gasparetto SEITOSEI ACTIFIN +33 6 21 10 49 24 ghislaine.gasparetto@seitosei-actifin.com	Press   Caroline Carmagnol  ALIZE RP +33 6 64 18 99 59 median@alizerp.com

1 | P a g e